Headlines and Highlights: A Review of the Latest Edition of Four Journals

03/25/16 • 45 min

This week, we debut a new format at the Rounds Table. Amol reviews articles published from the latest edition of four journals: Journal of the American Medical Association (JAMA), the Lancet, Annals of Internal Medicine and the New England Journal of Medicine (NEJM). Tune in to hear the latest medical findings, including mindfulness for back ...

The post Headlines and Highlights: A Review of the Latest Edition of Four Journals appeared first on Healthy Debate.

Send us a text

The post Headlines and Highlights: A Review of the Latest Edition of Four Journals appeared first on Healthy Debate.

Previous Episode

An Exercise in Contrasts: Contrast Induced Nephropathy and Exercise in Cancer

Send us a text

This week, Amol discusses contrast induced nephropathy. At an overall reported incidence of 10%, contrast induced nephropathy leads to worse clinical outcomes and double the rate of mortality. A systematic review and meta-analysis on the effectiveness of prevention strategies found that there is no strong evidence for any intervention beyond volume expansion with saline. N-acetyl ...

The post An Exercise in Contrasts: Contrast Induced Nephropathy and Exercise in Cancer appeared first on Healthy Debate.

Next Episode

Together Again: Aromatase Inhibitor for DCIS and New Colorectal Cancer Screening Recommendations

Send us a text

This week, Amol and Nathan discuss breast cancer and colorectal cancer: Two randomized control trials compared the aromatase inhibitor anastrozole to tamoxifen as adjuvant hormone therapy for postmenopausal women with ductal carcinoma in situ. Both trials were double blind and multi-centred, with one trial (NSABP B-35) enrolling North American patients and the other (IBIS-II DCIS) ...

The post Together Again: Aromatase Inhibitor for DCIS and New Colorectal Cancer Screening Recommendations appeared first on Healthy Debate.